| related words |
| corlux |
| therapy |
| nexavar |
| orphan |
| version |
| gene |
| soliris |
| designation |
| exclusivity |
| genetic |
| protein |
| approach |
| protocol |
| recothrom |
| cryoablation |
| tissue |
| melafind |
| marketed |
| surgeon |
| tarceva |
|
| related documents |
| 1157601--3/20/2008--SYNTA_PHARMACEUTICALS_CORP |
| 1157601--3/28/2007--SYNTA_PHARMACEUTICALS_CORP |
| 1338648--2/29/2008--Oracle_Healthcare_Acquisition_Corp. |
| 872912--3/12/2008--DELCATH_SYSTEMS_INC |
| 749647--3/27/2009--Celsion_CORP |
| 1183765--3/8/2010--THRESHOLD_PHARMACEUTICALS_INC |
| 1012140--2/29/2008--ONYX_PHARMACEUTICALS_INC |
| 1016504--9/28/2007--INTEGRATED_BIOPHARMA_INC |
| 1260990--3/15/2010--GTX_INC_/DE/ |
| 1061027--3/30/2006--SUNESIS_PHARMACEUTICALS_INC |
| 1142380--3/31/2006--CALLISTO_PHARMACEUTICALS_INC |
| 1162192--3/31/2006--AVALON_PHARMACEUTICALS_INC |
| 1128495--3/15/2006--ANADYS_PHARMACEUTICALS_INC |
| 1142380--4/15/2009--CALLISTO_PHARMACEUTICALS_INC |
| 821130--2/25/2010--UNITED_STATES_CELLULAR_CORP |
| 1051512--2/25/2010--TELEPHONE_&_DATA_SYSTEMS_INC_/DE/ |
| 1012140--2/25/2009--ONYX_PHARMACEUTICALS_INC |
| 1260990--3/3/2009--GTX_INC_/DE/ |
| 1124140--3/31/2009--EXACT_SCIENCES_CORP |
| 1317872--3/11/2010--TomoTherapy_Inc |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {operation, natural, condition} |
| {property, intellectual, protect} |
| {condition, economic, financial} |
| {regulation, government, change} |
| {financial, litigation, operation} |
| {system, service, information} |
| {cost, contract, operation} |
| {product, market, service} |
| {interest, director, officer} |
| {loss, insurance, financial} |
| {debt, indebtedness, cash} |
| {cost, operation, labor} |
| {operation, international, foreign} |
| {stock, price, share} |
| {acquisition, growth, future} |
| {investment, property, distribution} |
| {loan, real, estate} |
| {customer, product, revenue} |
|